Profile
AFIB ABT BSX-PA SYK BSX MDT
Company Name Acutus Medical, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $921.37K $183.08B $175.45B $126.35B $110.15B $100.91B
Employees 0.23K 114.00K 45.00K 52.00K 48.00K 95.00K
CEO Mr. Takeo Mukai Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Michael F. Mahoney Mr. Geoffrey Straub Martha
Ratings
AFIB ABT BSX-PA SYK BSX MDT
Quant Rating Score 2 1 3 1 3
Quant Rating Sell Strong Sell Neutral Strong Sell Neutral
Trading
AFIB ABT BSX-PA SYK BSX MDT
Last Close $0.031 $105.24 $122.18 $331.67 $74.92 $78.7
High 52 $0.76 $120.98 $122.18 $358.71 $78.59 $88.51
Low 52 $0.03 $90.19 $122.18 $253.85 $48.64 $69.43
Price vs. 52 Week High -95.92 % -13.01 % 0 % -7.54 % -4.67 % -11.08 %
Price vs. 52 Week Low 3.33 % 16.69 % 0 % 30.66 % 54.03 % 13.35 %
Total Return
AFIB ABT BSX-PA SYK BSX MDT
1 Month Return -24.39 % 0.56 % 0 % -2.6 % -2.7 % -0.79 %
3 Month Return -81.38 % -2.13 % 0 % -1.17 % 2.39 % -1.3 %
6 Month Return -86.7 % -6.04 % 0 % 6.52 % 22.56 % -9.06 %
9 Month Return -93.8 % 13.34 % 0 % 26.64 % 51.29 % 13.35 %
YTD Return -84.65 % -4.39 % 0 % 10.76 % 29.6 % -4.47 %
1 Year Return -95.37 % -6.58 % 0 % 17.61 % 42.33 % -11.08 %
3 Year Return 0 % -12.16 % 0 % 0 % 64.62 % -39.56 %
5 Year Return 0 % 18.85 % 0 % 0 % 77.16 % -23.78 %
Dividends
AFIB ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 2.05 % - 0.95 % - 3.52 %
Dividend Paid and Capex Coverage Ration (TTM) -690.57 % 1.22 % 2.66 % 1.96 % 2.64 % 1.29 %
Dividend Per Share (TTM) - 2.16 % - 3.15 % - 2.77 %
Payout Ratio (TTM) - 65.2 % 6.1 % 34.48 % 0.77 % 99.73 %
Growth
AFIB ABT BSX-PA SYK BSX MDT
Asset Growth -59.56 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth 79.82 % -9.7 % 14.01 % 12.78 % 14.01 % -5.14 %
Revenue Growth -56.22 % -8.12 % 12.29 % 11.11 % 12.29 % 3.64 %
Revenue 3 Year -66.81 % 18.09 % 40.06 % 41.29 % 40.06 % 8.85 %
Revenue 5 Year 91.57 % 32.35 % 37.78 % 48.53 % 37.78 % 7.41 %
Revenue 10 Year 91.57 % 63.34 % 84.02 % 126.63 % 84.02 % 43.65 %
EBIT Growth 47.47 % -22.53 % 42.09 % 36.85 % 42.09 % 4.5 %
Net Income Growth -106.14 % -17.45 % 128.22 % 34.22 % 128.22 % -2.18 %
Net Income 3 Yeari Growth Per Share 68.6 % 29.73 % 1209.43 % 95.8 % 1209.43 % 3.26 %
Net Income 5 Yeari Growth Per Share 1.27 % 143.85 % -9.39 % -12.21 % -9.39 % -19.5 %
Net Income 10 Yeari Growth Per Share 1.27 % 97.66 % 1315.23 % 213.78 % 1315.23 % -9.48 %
Operating Income Growth 47.47 % -22.53 % 42.09 % 36.85 % 42.09 % 4.5 %
Operating Cash Flow Growth (CFG) 25.2 % -24.21 % 64.02 % 41.43 % 64.02 % 12.39 %
Operating 3 Year CFG 70.72 % -6.36 % 61.83 % 12.02 % 61.83 % 10.18 %
Operating 5 Year CFG -9.06 % 16.29 % 667.41 % 40.12 % 667.41 % -1.78 %
Operating 10 Year CFG -9.06 % 94.35 % 113.53 % 96.25 % 113.53 % 3.3 %
EPS Growth -102.16 % -16.24 % 140 % 33.87 % 140 % -2.12 %
EPS Diluted Growth -102.16 % -16.62 % 137.78 % 33.71 % 137.78 % -2.13 %
Book Value Per Share -101.15 % 6.01 % 8.01 % 11.49 % 8.01 % -2.31 %
Share Holder 3 Year Equity Growth Per Share -100.27 % 19.98 % 22.65 % 40.57 % 22.65 % -1.1 %
Share Holder 5 Year Equity Growth Per Share 99.61 % 27.6 % 110.04 % 56.21 % 110.04 % 1.66 %
Share Holder 10 Year Equity Growth Per Share 99.61 % 36.45 % 172.17 % 104.97 % 172.17 % 94.93 %
Dividend Per Share Growth - 8.27 % -49.88 % 7.97 % -49.88 % 1.54 %
Dividend 3 Year Growth Per Share - 41.54 % -2.5 % 30.56 % -2.5 % 19.02 %
Dividend 5 Year Growth Per Share - 81.76 % - 59.67 % - -
Dividend 10 Year Growth Per Share - 258.71 % - 183.29 % - 147.94 %
Debt Growth -0.97 % -10.4 % 2.26 % -0.41 % 2.26 % 6.91 %
Free Cash Flow Growth 28.3 % -35.17 % 86.32 % 54.03 % 86.32 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
AFIB ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM -8.26 % 54.38 % 68.75 % 63.09 % 68.89 % 64.27 %
Return on Assets TTM -160.72 % 7.67 % 2.74 % 8.53 % 4.98 % 4.09 %
Return on Equity TTM -379.7 % 14.62 % 5.13 % 18.41 % 9.57 % 7.19 %
Return on Capital Employed TTM 15.74 % 11.64 % 6.66 % 12.73 % 8.72 % 7.09 %
Net Income Per EBT TTM -2788.01 % 85.37 % 63.08 % 85.81 % 85.16 % 76 %
EBT Per Ebit TTM 48 % 95.64 % 74.52 % 94.87 % 77.39 % 86.1 %
EBIT Per Revenue TTM 75.59 % 16.71 % 14.71 % 19.7 % 18.18 % 17.36 %
Cash Flow To Debt Ratio TTM -165.16 % 48.97 % 18.94 % 26.97 % 22.52 % 26.98 %
Receivables Turnover TTM 0.85 6.17 6.28 6.04 6.61 5.28
Payables Turnover TTM 2.26 4.45 4.7 6.21 5.14 4.8
Inventory Turnover TTM 1.22 2.72 1.99 1.54 1.85 2.22
Fixed Asset Turnover TTM 171.73 % 402.94 % 453.27 % 643.04 % 457.71 % 453.09 %
Asset Turnover TTM 15.89 % 56.2 % 39.66 % 53.2 % 41.53 % 35.97 %
Operating Cash Flow Per Share TTM -2.14 4.12 1.24 9.12 1.68 5.13
Free Cash Flow Per Share TTM -2.14 2.84 0.81 7.51 1.06 3.93
Cash Per Share TTM 67.2 % 383.55 % 39.7 % 632.75 % 276.01 % 605.38 %
Operating Cash Flow Sales Ratio TTM -959.7 % 17.54 % 13.6 % 16.55 % 16.27 % 20.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.14 % 68.92 % 65.5 % 82.36 % 62.7 % 76.62 %
Cash Flow Coverage Ratios TTM -165.16 % 48.97 % 18.94 % 26.97 % 22.52 % 26.98 %
Price To Free Cash Flows Ratio TTM -0.01 37.19 94.79 44.21 70.92 19.41
Price To Operating Cash Flows Ratio TTM -0.01 25.55 60.64 36.36 44.48 15.33
Price Cash Flow Ratio TTM -0.01 25.55 60.64 36.36 44.48 15.33
Income Statement (TTM)
AFIB ABT BSX-PA SYK BSX MDT
Revenue $0.01B $40.11B $14.24B $20.5B $14.24B $32.36B
Gross Profit $-0B $22.13B $9.9B $13.06B $9.9B $19.45B
Gross Profit Ratio -43.79% 55.18% 69.49% 63.7% 69.49% 60.11%
EBITDA $-0.01B $10.59B $3.62B $4.95B $3.62B $8.38B
Net Income $-0.08B $5.72B $1.59B $3.17B $1.59B $3.68B
EPS Diluted -2.81 3.26 1.07 8.25 1.07 2.76
Balance Sheet (MRQ)
AFIB ABT BSX-PA SYK BSX MDT
Long Term Debt $0.03B $13.6B $8.96B $10.9B $8.96B $23.88B
Total Liabilities $0.05B $34.39B $15.61B $21.32B $15.61B $39.56B
Total Equity $-0B $38.83B $19.53B $18.59B $19.53B $50.42B
Total Investments $0B $1.18B $0.41B $0.08B $0.41B $8.34B
Total Debt $0.04B $15.87B $9.49B $13B $9.49B $26.05B
Total Assets $0.05B $73.21B $35.14B $39.91B $35.14B $89.98B
Cash Flow Statement (TTM)
AFIB ABT BSX-PA SYK BSX MDT
Net Income $-0.01B $5.7B $1.59B $3.17B $1.59B $3.68B
Inventory $-0B $-0.23B $-0.66B $-0.8B $-0.66B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-0.03B $-3.67B
Operating Cash Flow $-0.06B $7.26B $2.5B $3.71B $2.5B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.58B $-0.8B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 105.24
AEMD Aethlon Medical, Inc. 0.3675
AHCO AdaptHealth Corp. 11.22
AHPI Allied Healthcare Products, Inc. 0.5501
ALGN Align Technology, Inc. 220.45
ALUR Allurion Technologies Inc. 0.8596
AMIX Autonomix Medical, Inc. Common Stock 1.29
ANIK Anika Therapeutics, Inc. 27.9
AORT Artivion, Inc. 27.48
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.34
ASXC Asensus Surgical, Inc. 0.3391
ATEC Alphatec Holdings, Inc. 10.91
AVNS Avanos Medical, Inc. 23.14
AXDX Accelerate Diagnostics, Inc. 1.3
AXGN AxoGen, Inc. 9.24
AXNX Axonics, Inc. 68.49
AZYO Aziyo Biologics, Inc. 1.49
BBLG Bone Biologics Corporation 1.99
ETFs With Exposure to AFIB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 269.69
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00002 119.77
VXF Vanguard Extended Market Index Fund 0 178.79
VFLQ Vanguard U.S. Liquidity Factor ETF 0.04 99.7611
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
Unlock